Bortz Blood Age is a biological age model developed by Humanity Inc. and implemented by Zsolt Szabo at longevity-tools.com. It uses up to 22 biomarkers from standard blood panels to estimate biological age acceleration.
The model was trained on 306,000 individuals from the UK Biobank (adults aged 38–73) using a Cox proportional hazards framework. It reports an 11% relative increase in predictive value over the Levine PhenoAge model.
Unlike PhenoAge (which uses a Gompertz mortality model), Bortz computes a Biological Age Acceleration (BAA) score by centering each biomarker around the population mean, weighting by trained coefficients, and summing. The result is added to your chronological age to get your Bortz Blood Age.
The model works best with all 22 biomarkers but can produce a result with just 7 core markers (creatinine, cystatin C, GGT, RDW, ALT, vitamin D, and age). Missing optional biomarkers are assumed to be at the population mean (contributing zero to the score).
Note: The model was trained on adults aged 38–73. Outside this range, accuracy decreases and results may overestimate biological age, especially after age 80.
Both models estimate biological age from blood tests, but they differ in important ways:
Both share several biomarkers (albumin, creatinine, CRP, ALP, MCV, RDW, lymphocytes, glucose) but Bortz adds cystatin C, GGT, HbA1c, cholesterol, urea, RBC, ALT, SHBG, vitamin D, MCH, ApoA1, and monocyte/neutrophil counts.